CN1108160C - 一种治疗口腔溃疡的药物及制备方法 - Google Patents
一种治疗口腔溃疡的药物及制备方法 Download PDFInfo
- Publication number
- CN1108160C CN1108160C CN00111161A CN00111161A CN1108160C CN 1108160 C CN1108160 C CN 1108160C CN 00111161 A CN00111161 A CN 00111161A CN 00111161 A CN00111161 A CN 00111161A CN 1108160 C CN1108160 C CN 1108160C
- Authority
- CN
- China
- Prior art keywords
- medicine
- vermilion
- borax
- oral ulcer
- white cocoon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 52
- 238000002360 preparation method Methods 0.000 title claims abstract description 7
- 229940079593 drug Drugs 0.000 title description 9
- 239000000843 powder Substances 0.000 claims abstract description 17
- 229910021538 borax Inorganic materials 0.000 claims abstract description 15
- 239000004328 sodium tetraborate Substances 0.000 claims abstract description 15
- 235000010339 sodium tetraborate Nutrition 0.000 claims abstract description 15
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 208000002399 aphthous stomatitis Diseases 0.000 claims description 22
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 claims description 13
- 208000007117 Oral Ulcer Diseases 0.000 claims description 13
- 238000012545 processing Methods 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 2
- 208000025865 Ulcer Diseases 0.000 abstract description 20
- 231100000397 ulcer Toxicity 0.000 abstract description 20
- 241000218202 Coptis Species 0.000 abstract 2
- 235000002991 Coptis groenlandica Nutrition 0.000 abstract 2
- 235000000177 Indigofera tinctoria Nutrition 0.000 abstract 2
- 229940037003 alum Drugs 0.000 abstract 2
- 229940097275 indigo Drugs 0.000 abstract 2
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 abstract 2
- 210000000214 mouth Anatomy 0.000 description 11
- 230000000694 effects Effects 0.000 description 6
- 230000035876 healing Effects 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 5
- 230000000306 recurrent effect Effects 0.000 description 5
- 235000005911 diet Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 210000003491 skin Anatomy 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 231100000957 no side effect Toxicity 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 206010007134 Candida infections Diseases 0.000 description 2
- 108010022355 Fibroins Proteins 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229910017052 cobalt Inorganic materials 0.000 description 2
- 239000010941 cobalt Substances 0.000 description 2
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 210000002200 mouth mucosa Anatomy 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 210000003800 pharynx Anatomy 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 244000293323 Cosmos caudatus Species 0.000 description 1
- 235000005956 Cosmos caudatus Nutrition 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010013887 Dysarthria Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241001191009 Gymnomyza Species 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- 208000007027 Oral Candidiasis Diseases 0.000 description 1
- 244000179560 Prunella vulgaris Species 0.000 description 1
- 241000382353 Pupa Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 241000287411 Turdidae Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 201000003465 angular cheilitis Diseases 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 238000001354 calcination Methods 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 208000007287 cheilitis Diseases 0.000 description 1
- 229910052956 cinnabar Inorganic materials 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000007905 drug manufacturing Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000028161 membrane depolarization Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 229940037201 oris Drugs 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 208000026473 slurred speech Diseases 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明提供一种治疗口腔溃疡的药物及制备方法,该药物是有白茧5~25、黄连5~20、青黛5~20、枯矾5~15、硼砂5~15、银朱1~5重量份的原料制成的药剂,该药物是将黄连、青黛、枯矾、硼砂、银朱分别加工粉碎成200目细度;将白茧焙酥,加工粉碎成200目细度;然后将上述的全部细粉组分按所述比例混合并灭菌后制得。
Description
本发明涉及一种用于治疗复发性口疮的药物,尤其是一种以中药为主要原料制备的治疗复发性口疮的药物,本发明还涉及该药物的制备方法。
复发性口疮是一种临床最常见的口腔粘膜疾病,男女老少都可发生,以中青年居多,人群患病率超过10%。该病是一种以周期性反复发作为特点的口腔粘膜局限性溃疡损害,可发生于口腔粘膜的任何部位,以唇、颊、舌部位多见,严重者可殃及咽部粘膜,不少患者随着病情的延长,溃疡面积增大、数目增多,疼痛加重,愈合期延长,间隔期缩短而严重妨碍进食和说话,影响生活质量。
复发性口疮的发病原因,祖国医学认为多缘于脾胃积热、虚火上炎,现代医学研究则众说纷纭,至今尚无定论,因此,也就没有特异性有效药物和治疗方法。现在临床上使用的药物一般都有一定的疗效,可以减轻局部症状,促进溃疡愈合,但药的成本较高,一般需半小时见效,缺少营养成分,溃疡愈合较慢,有刺激性或有毒副作用等,制药工艺也较复杂。
本发明的目的之一是为口腔溃疡患者提供一种成本低,起效快,含有营养成分,溃疡愈合迅速,无刺激性和无毒副作用的药物。目的之二是提供一种达到目的之一的工艺简单,易于操作的药物制备方法。
本发明的目的之一可通过如下措施来实现:
本发明药物是有下列组分制成的:(用量为重量份)
白茧 5~25 黄连 5~20
青黛 5~20 枯矾 5~15
硼砂 5~15 银朱 1~5
制备本发明药物的配方优选重量(份)配比范围是:
白茧 5~15 黄连 8~15
青黛 8~15 枯矾 6~10
硼砂 6~10 银朱 1~3
本发明药物的最佳重量(份)配比是:
白茧 12 黄连 8
青黛 10 枯矾 10
硼砂 6、5 银朱 1、5
本发明所说的药剂是任何一种药剂学上所说的剂型;所说的药剂剂型以散剂或贴膜为优选方案。
将上述各组分制成本发明药物的生产方法是:
先取黄连、青黛、枯矾、硼砂、银朱分别加工粉碎成200目细度;将白茧焙酥,加工粉碎成200目细度;然后将上述的全部细粉组分按所述比例混合并灭菌后制得本发明药物。
本发明所述药物,制成粉剂后可装入喷粉剂专用塑料瓶,也可将药粉用医用赋性剂制成贴膜。
本发明所述的灭菌是常规的紫外线或钴60室灭菌。
本发明组分所述的白茧是蚕将变成蛹时吐丝做成的巢,所述的白茧可以用真丝或纯真丝制品代替。
本发明是利用无毒副作用的中药为口腔溃疡患者提供一种成本低并可迅速达到临床治愈目的的药物。本发明由白茧、黄连、青黛、枯矾、硼砂、银朱为原料制成。方中白茧为君,黄连、青黛为臣,佐以枯矾、硼砂、银朱。白茧的主要成分是低分子的氨基酸,内含有丝蛋白,它的分子结构与构成皮肤的胶原蛋白相似,与人体皮肤接触时能增强其弹性及活力。还具有良好的改善毛细血管、促进血运、促进皮肤表层脂膜新陈代谢的作用,白茧中的蛋白质和主要氨基酸含量比珍珠高,丝素中所含的天然蛋白质——亮氨酸可以迅速加快细胞的新陈代谢,促进伤口及溃疡愈合,并有一定的抗炎作用。丝氨酸、苏氨酸还具有激活皮肤细胞机能的作用,白茧粉在口腔经酶迅速分解成具有上述治疗作用的蛋白质、氨基酸,因此,白茧是一种尚未被人们发现和利用的用于治疗口腔溃疡的良药。方中黄连清热燥湿、泻火解毒,能抑制多种病菌,并有良好的抗炎、抗溃疡的作用,被人们称作中药的抗生素王。青黛清热凉血解毒,古医籍《圣惠方》载能治口舌生疮,现代研究还表明能改善人体免疫能力,用于治疗白血病等有效。枯矾为白矾经加热溶化并煅烧至枯干而得,经煅烧后其对皮肤粘膜的刺激作用大大减弱,枯矾功能燥湿、收敛解毒、止血,具有抗菌、去腐、收敛作用,古人早已用于治疗口舌生疮、喉痹、齿痛、乳蛾等口腔内疮疡。硼砂功能清热解毒、防腐,是治疗咽喉内肿痛、口舌生疮的良药。银朱为人工制成的赤色硫化汞,传统认为银朱系水银加工而成,故有毒,现代研究证明银朱在胃中不被吸收,故小量入口安全无毒,《急救方》一书中谓可治咽喉疼痛,银朱功能燥湿、杀虫且攻毒。经研究和临床应用证明银朱在溃疡面有很强的附着力,用银朱与以上各味药配伍,能更好地发挥治疗作用。综观全方,组方立意新颖,科学先进,既符合祖国医药学理论,又符合现代医药学研究。以白茧为主制备的药物用于治疗复发性口疮及其他口腔疮疡,每治一例病人,所用药物成本只需几角钱,用药后即刻见效,经近二十年上万例患者应用证明,未发现有无效的病例,本发明的药物具有丰富的促进伤口愈合的营养成分,一般患者溃疡愈合需2~3天,复发的现象很少见,另外,无刺激性和无毒副作用。该药物还可广泛用于鹅口疮、口边炎等口腔疮溃,另曾有我国援非医疗队专家带去非洲,用于治疗爱滋病人口腔念珠菌感染所致溃疡,效果良好。
典型病例:
1、杜XX,男,49岁,武装部干部,5年前患脑中风,经治疗后仍半身不遂,言语不清,长年卧床,自1999年底发现口腔溃疡,以舌颊部多见,在某医院用中西药治疗无效,2000年元旦过后,溃疡蔓延至整个口腔,持续发作,无明显周期,疼痛难忍,饮食非常困难,于2000年2月6日前来求治。令其陪伴家属将本发明药物带回家,取消毒棉签蘸生理盐水后再蘸本药粉遍涂患处,一日数次,重点溃疡面用消毒纱布沾上药粉贴塞,经一周治疗,病人自述:第一次上药后即时疼痛明显减轻,当日饮食即有所改善,3日后溃疡个数明显减少,溃疡面缩小,继续用药一周,溃疡痊愈,随访至今无复发。
2、许氏,女,68岁,家庭妇女,口腔溃疡,反复发作,久治不愈3年,于1999年7月26日来诊,自述从年轻即不喜欢吃瓜果和蔬菜,长期便秘,每逢农忙季节或天气干燥就上火,口舌生疮,外用冰硼散,内服消炎药,均无效,服一段泄火的中药可暂时减轻,最近发作严重,唇、舌、颊、咽弥漫性溃疡,疼痛难忍,影响饮食和言语,诊断为口腔溃疡,使用本发明药粉喷撒治疗,一日数次,一周后复诊,患者自述第一次刚用药即感疼痛减轻,三日后溃疡个数大减,溃疡面明显缩小,饮食言语基本恢复正常,用药一周,除极个别面积大而深的溃疡面尚未彻底愈合外,其余均愈合,继用药三日,获痊愈,随访至今未复发。
实施例:
按下述配比称取原料(千克):
白茧 12 黄连 10
青黛 10 枯矾 8、5
硼砂 8、5 银朱 2
生产方法如下:
a、取黄连、青黛、枯矾、硼砂、银朱分别加工粉碎,过200目筛,备用;
b、将白茧焙酥,加工粉碎,过200目筛,备用;
c、将上述a、b两工序的细粉置入混合筒混匀;
d、取喷粉剂专用塑料瓶经紫外线消毒,在制剂室内灌装,每瓶3克,灌装密封好后贴标签并放钴60室灭菌,从而制得本发明的粉剂。
Claims (6)
1、一种治疗口腔溃疡的药物,其特征在于它是有下述重量配比的原料制成的药剂
白茧 5~25 黄连 5~20
青黛 5~20 枯矾 5~15
硼砂 5~15 银朱 1~5
2、根据权利要求1所述的治疗口腔溃疡的药物,其中各原料的重量配比是
白茧 5~15 黄连 8~15
青黛 8~15 枯矾 6~10
硼砂 6~10 银朱 1~3
3、根据权利要求1所述的治疗口腔溃疡的药物,其中各原料的重量配比是
白茧 12 黄连 8
青黛 10 枯矾 10
硼砂 6、5 银朱 1、5
4、根据权利要求1、2或3所述的治疗口腔溃疡的药物,其特征在于所说的药剂是任何一种药剂学上所说的剂型。
5、根据权利要求4所述的治疗口腔溃疡的药物,其特征在于所说的药剂是散剂或贴膜。
6、权利要求1所述的治疗口腔溃疡的药物的制备方法,其特征在于先取黄连、青黛、枯矾、硼砂、银朱分别加工粉碎成200目细度;将白茧焙酥,加工粉碎成200目细度;然后将上述的全部细粉组分按所述比例混合并灭菌后制得本发明药物。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN00111161A CN1108160C (zh) | 2000-06-30 | 2000-06-30 | 一种治疗口腔溃疡的药物及制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN00111161A CN1108160C (zh) | 2000-06-30 | 2000-06-30 | 一种治疗口腔溃疡的药物及制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1281708A CN1281708A (zh) | 2001-01-31 |
| CN1108160C true CN1108160C (zh) | 2003-05-14 |
Family
ID=4581098
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN00111161A Expired - Fee Related CN1108160C (zh) | 2000-06-30 | 2000-06-30 | 一种治疗口腔溃疡的药物及制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1108160C (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100386091C (zh) * | 2004-04-22 | 2008-05-07 | 王松林 | 治疗溃疡病的药物及制备方法 |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105213594A (zh) * | 2015-11-07 | 2016-01-06 | 杜卫卫 | 一种治疗鹅口疮的药物组合制剂 |
-
2000
- 2000-06-30 CN CN00111161A patent/CN1108160C/zh not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100386091C (zh) * | 2004-04-22 | 2008-05-07 | 王松林 | 治疗溃疡病的药物及制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1281708A (zh) | 2001-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1244361C (zh) | 一种治疗口腔咽喉疾病的药物组合物及其制备方法和用途 | |
| CA2304596A1 (en) | A medicament for treating recurrent ulcer of mouth and behcet's syndrome | |
| CN108743621A (zh) | 冰晶态的熊胆粉和制备方法 | |
| CN1108160C (zh) | 一种治疗口腔溃疡的药物及制备方法 | |
| CN1150927C (zh) | 一种治疗急慢性咽喉炎,扁桃体炎的药物及其生产方法 | |
| CN1088354C (zh) | 清除狐臭粉 | |
| CN100364512C (zh) | 一种喉疾灵新制剂及其用途 | |
| CN116098225A (zh) | 一种治愈慢性结肠炎的功能食品 | |
| CN1284585C (zh) | 治疗急慢性咽喉炎、复发性口腔溃疡的药物及制备方法 | |
| CN1209152C (zh) | 一种除疣痣组合物及其制备方法 | |
| CN1062465C (zh) | 双五降糖胶囊 | |
| CN108815132A (zh) | 一种三氧活性油软胶囊及其制备方法与应用 | |
| CN1233398C (zh) | 一种治疗口腔溃疡的药剂 | |
| CN1030184A (zh) | 炎立消的制造方法 | |
| CN101919799B (zh) | 缓释透皮给药系统 | |
| CN1255174C (zh) | 一种治疗婴幼儿腹泻腹痛的贴脐散 | |
| CN1289144C (zh) | 治疗放射性黏膜损伤、复发性口疮、牙周炎的药物 | |
| CN1248697C (zh) | 一种治疗慢性肠炎的药物组合物及其制备方法 | |
| CN105944089A (zh) | 一种治疗萎缩性胃炎的胶囊剂及其制备方法 | |
| CN118750549A (zh) | 一种治疗儿童慢性鼻窦炎的中药组合物及其复合制剂 | |
| CN1291752C (zh) | 一种治疗牛皮癣的中药外敷药组合物及其制备方法 | |
| CN1615969A (zh) | 一种治疗巴氏囊肿、疖、疔、疮、痈的中药制剂拔毒膏 | |
| CN104644945B (zh) | 口疮消痛散以及制备方法 | |
| CN113082199A (zh) | 一种肾病药物组合物及其制备方法 | |
| CN119033891A (zh) | 用于治疗低血压的中药组合物及其制备方法和应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |